» Articles » PMID: 38753051

Multiple Endocrine Neoplasia Type 2B Diagnosed After Small Intestinal Volvulus with Progressive Megacolon in an Adolescent

Overview
Specialty Gastroenterology
Date 2024 May 16
PMID 38753051
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple endocrine neoplasia type 2B is a rare autosomal dominant disease characterized by the presence of medullary thyroid carcinoma, pheochromocytoma, Marfan-like fatigue, a peculiar face with thickening of the lips, mucosal neuromas on the lips and tongue, and gastrointestinal phenomena. Most patients harbor pathological variants of the RET gene. Herein, we present the first case of a 14 year-old boy who experienced small intestinal volvulus along with a megacolon, and he was diagnosed with multiple endocrine neoplasia type 2B. The patient complained of constipation since he was 2 years old and slowly progressive abdominal distension at school age. At 14 years of age, he presented with remarkable megacolon mimicking Hirschsprung's disease and complicated with small intestinal volvulus. The volvulus was successfully repaired, and the particularly dilated transverse colon was resected following a rectal biopsy. Histopathological evaluation of the resected transverse colon revealed to be compatible with ganglioneuromatosis. After emergency surgery, the patient was diagnosed with multiple endocrine neoplasia type 2B with medullary thyroid carcinoma, and a de novo variant of RET was confirmed. Gastroenterologists should consider it when treating patients with constipation, especially those with megacolon. Therefore, timely diagnosis may lead to appropriate treatment of medullary thyroid carcinoma and improve mortality.

Citing Articles

3 in 1: Manifestations of Multiple Endocrine Neoplasia Type 2B on Imaging.

Belcher V, Hinshaw T, Field J, Haider A JCEM Case Rep. 2025; 3(2):luaf004.

PMID: 39866916 PMC: 11758192. DOI: 10.1210/jcemcr/luaf004.

References
1.
Machens A, Lorenz K, Sekulla C, Hoppner W, Frank-Raue K, Raue F . Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium. Eur J Endocrinol. 2012; 168(3):307-14. DOI: 10.1530/EJE-12-0919. View

2.
Brauckhoff M, Gimm O, Weiss C, Ukkat J, Sekulla C, Brauckhoff K . Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg. 2004; 28(12):1305-11. DOI: 10.1007/s00268-004-7637-4. View

3.
Goncharova M, Grey J, Druce M . Impact of gastrointestinal symptoms on quality of life in MEN2. Clin Endocrinol (Oxf). 2020; 94(4):606-615. DOI: 10.1111/cen.14366. View

4.
Brauckhoff M, Machens A, Hess S, Lorenz K, Gimm O, Brauckhoff K . Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. Surgery. 2008; 144(6):1044-50. DOI: 10.1016/j.surg.2008.08.028. View

5.
Gibbons D, Camilleri M, Nelson A, Eckert D . Characteristics of chronic megacolon among patients diagnosed with multiple endocrine neoplasia type 2B. United European Gastroenterol J. 2016; 4(3):449-54. PMC: 4924433. DOI: 10.1177/2050640615611630. View